Literature DB >> 26043173

Functional analyses of polymorphic variants of human terminal deoxynucleotidyl transferase.

A Troshchynsky1, I Dzneladze1, L Chen2, Y Sheng1, V Saridakis1, G E Wu1,2,3.   

Abstract

Human terminal deoxynucleotidyl transferase (hTdT) is a DNA polymerase that functions to generate diversity in the adaptive immune system. Here, we focus on the function of naturally occurring single-nucleotide polymorphisms (SNPs) of hTdT to evaluate their role in genetic-generated immune variation. The data demonstrate that the genetic variations generated by the hTdT SNPs will vary the human immune repertoire and thus its responses. Human TdT catalyzes template-independent addition of nucleotides (N-additions) during coding joint formation in V(D)J recombination. Its activity is crucial to the diversity of the antigen receptors of B and T lymphocytes. We used in vitro polymerase assays and in vivo human cell V(D)J recombination assays to evaluate the activity and the N-addition levels of six natural (SNP) variants of hTdT. In vitro, the variants differed from wild-type hTdT in polymerization ability with four having significantly lower activity. In vivo, the presence of TdT varied both the efficiency of recombination and N-addition, with two variants generating coding joints with significantly fewer N-additions. Although likely heterozygous, individuals possessing these genetic changes may have less diverse B- and T-cell receptors that would particularly effect individuals prone to adaptive immune disorders, including autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26043173     DOI: 10.1038/gene.2015.19

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  51 in total

1.  A RAG-1/RAG-2 tetramer supports 12/23-regulated synapsis, cleavage, and transposition of V(D)J recombination signals.

Authors:  Patrick C Swanson
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

2.  A gradient of template dependence defines distinct biological roles for family X polymerases in nonhomologous end joining.

Authors:  Stephanie A Nick McElhinny; Jody M Havener; Miguel Garcia-Diaz; Raquel Juárez; Katarzyna Bebenek; Barbara L Kee; Luis Blanco; Thomas A Kunkel; Dale A Ramsden
Journal:  Mol Cell       Date:  2005-08-05       Impact factor: 17.970

3.  Terminal deoxynucleotidyl transferase deficiency reduces the incidence of autoimmune nephritis in (New Zealand Black x New Zealand White)F1 mice.

Authors:  C Conde; S Weller; S Gilfillan; L Marcellin; T Martin; J L Pasquali
Journal:  J Immunol       Date:  1998-12-15       Impact factor: 5.422

Review 4.  The origins of V(D)J recombination.

Authors:  S M Lewis; G E Wu
Journal:  Cell       Date:  1997-01-24       Impact factor: 41.582

5.  Crystal structures of a template-independent DNA polymerase: murine terminal deoxynucleotidyltransferase.

Authors:  M Delarue; J B Boulé; J Lescar; N Expert-Bezançon; N Jourdan; N Sukumar; F Rougeon; C Papanicolaou
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

6.  Extrachromosomal DNA substrates in pre-B cells undergo inversion or deletion at immunoglobulin V-(D)-J joining signals.

Authors:  J E Hesse; M R Lieber; M Gellert; K Mizuuchi
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

Review 7.  The mechanism of V(D)J joining: lessons from molecular, immunological, and comparative analyses.

Authors:  S M Lewis
Journal:  Adv Immunol       Date:  1994       Impact factor: 3.543

8.  Diketo hexenoic acid derivatives are novel selective non-nucleoside inhibitors of mammalian terminal deoxynucleotidyl transferases, with potent cytotoxic effect against leukemic cells.

Authors:  Giada A Locatelli; Roberto Di Santo; Emmanuele Crespan; Roberta Costi; Alessandra Roux; Ulrich Hübscher; Igor Shevelev; Giuseppina Blanca; Giuseppe Villani; Silvio Spadari; Giovanni Maga
Journal:  Mol Pharmacol       Date:  2005-05-18       Impact factor: 4.436

9.  Mutational analysis of terminal deoxynucleotidyltransferase-mediated N-nucleotide addition in V(D)J recombination.

Authors:  Jamie A E Repasky; Elizabeth Corbett; Cristian Boboila; David G Schatz
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

Review 10.  The old and the restless.

Authors:  S M Lewis; G E Wu
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

View more
  1 in total

1.  T cell receptor β-chains display abnormal shortening and repertoire sharing in type 1 diabetes.

Authors:  Iria Gomez-Tourino; Yogesh Kamra; Roman Baptista; Anna Lorenc; Mark Peakman
Journal:  Nat Commun       Date:  2017-11-27       Impact factor: 14.919

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.